• PIN34 Development of Treatment Costs of Patients Undergoing Remission Induction Chemotherapy- A Historical Comparison Before and After Introduction of Posaconazole Prophylaxis

    Nov 1, 2012, 00:00

  • PHP184 Changing Margins in Pharmaceutical Distribution- Who Benefits from the New Slicing of the Pie?

    Nov 1, 2012, 00:00

  • PRM54 Correlating Cost Effectiveness Output With Patient Level Data Input via the IMS Core Diabetes Model (CDM)

    Nov 1, 2012, 00:00

  • PND37 The Cost-Effectiveness of Buccolam® (Licensed Oromucosal Midazolam) for the Treatment of Acute Epileptic Seizures in the UK; a Hybrid Model Solution

    Nov 1, 2012, 00:00

  • PIH7 Net Tax Revenue with a National Based Rotavirus Vaccination Program in Turkey

    Nov 1, 2012, 00:00

  • PHP139 Which Criteria are Considered in Health Care Decisions? Insights from an International Survey of Policy and Clinical Decision Makers

    Nov 1, 2012, 00:00

  • PMH30 Cost-Minimization-Analysis of Paliperidon Palmitate in the Treatment of Schizophrenia in Austria

    Nov 1, 2012, 00:00

  • PSS2 Comparisons of the Clinical Effectiveness of Treatments for Macular Oedema (MO) Caused by Retinal Vein Occlusion (RVO)

    Nov 1, 2012, 00:00

  • PHP87 Evaluation of Real Life Use of Sugammadex for Decurarization of Neuromuscular Blockade in Surgical Interventions in Belgium

    Nov 1, 2012, 00:00

  • PHP107 Experts' Views on the Introduction of a Monopsony in Health Care Services in Greece

    Nov 1, 2012, 00:00

  • PGI25 Cost-Utility Analysis of Telaprevir in Combination With Peginterferon Alpha and Ribavirin in Previously Treated Patients With Chronic Hepatitis C

    Nov 1, 2012, 00:00

  • PHP27 Implementation of the Transparency Directive in Hungary- Special Focus on Time Limits for Pricing and Reimbursement Decisions

    Nov 1, 2012, 00:00

  • PGI3 Determination of Efficacy, Adverse Drug Reactions and Cost Effectiveness of Three Triple Drug Regimens for the Treatment of H. Pylori Infected Acid Peptic Disease Patients

    Nov 1, 2012, 00:00

  • PHP126 From Innovation to Market Access- Reimbursement Strategies of Medical Industry in Dutch Health Care

    Nov 1, 2012, 00:00

  • PDB29 Glycemic Control and Diabetes-Related Health Care Costs in Type 2 Diabetes. A Retrospective Analysis Based on Administrative and Clinical Data

    Nov 1, 2012, 00:00

  • PSS15 A New Insight Into Cost-Effectiveness Analyses in Atopic Dermatitis- The Tacrolimus 0.1% Ointment Versus Ciclosporin Comparison

    Nov 1, 2012, 00:00

  • PDB6 Predictors of Reaching HbA1C Goal in T2Dm Patients Using Dipeptidyl Peptidase-4 Inhibitors (DPP4Is) Combination Therapy- A Subgroup Analysis

    Nov 1, 2012, 00:00

  • PDB5 Statin is a Reasonable Treatment Option for Patients With Polysystic Ovary Syndrome- A Meta-Analysis of Randomized Controlled Trials

    Nov 1, 2012, 00:00

  • PCN103 How Much Price Component is Accounted for in State Drugs Purchase Decisions in Ukrainian Oncology?

    Nov 1, 2012, 00:00

  • MA4 Adequate Adherence to Intranasal Corticosteroids is Associated With Significantly Reduced Number and Costs of Outpatient Visits Among Patients Newly Diagnosed With Allergic Rhinitis

    Nov 1, 2012, 00:00

  • PCN97 Pharmacoeconomic Analysis of the Prostate Cancer Therapy with Gonadotropin-Releasing Hormone Analogues- Leuprorelin, Goserelin, Triptorelin

    Nov 1, 2012, 00:00

  • PMH43 Modelling the Longitudinal Latent Effect of Pregabalin on Self-Reported Changes in Sleep Disturbances and Disability in Outpatients With Generalized Anxiety Disorder (GAD) Treated in Routine Clinical Practice in Spain

    Nov 1, 2012, 00:00

  • PMD78 The Switch Study- The Impact of Continuous Glucose Monitoring on Quality of Life and Treatment Satisfaction

    Nov 1, 2012, 00:00

  • PIN7 Estimate of Infectious Disease Burden Attributable to Climate Change

    Nov 1, 2012, 00:00

  • PIN36 Six Years Observational Study of the Cost of Highly Active Antiretroviral Therapy and HIV/AIDS Control

    Nov 1, 2012, 00:00

  • PUK5 Clinical and Economic Impacts of Clinical Pharmacy Education on Infection Management Among Patents With Chronic Kidney Disease in a Hospital (Indonesia)

    Nov 1, 2012, 00:00

  • PCV40 Pharmacotherapy Cost of Patients With Hypertension in Bulgaria

    Nov 1, 2012, 00:00

  • PMD11 The Cost of Poor Sample Quality- Assessing the Financial Impact of Sample Rejection and Recollection in Health Care Insitutions

    Nov 1, 2012, 00:00

  • PCN25 A Population-Based Prediction of Breast Cancer in Russian Federation- Analysis HER2-Status Groups for Target Treatment

    Nov 1, 2012, 00:00

  • PRS21 Cost-Effectiveness of Budesonide/Formoterol Versus Fluticasone/Salmeterol Based on Real-World Effectiveness in Patients With COPD

    Nov 1, 2012, 00:00

  • PND11 Estimating Survival-Benefit of New Therapeutic Interventions in Cystic Fibrosis Patients in Germany, France, UK and Ireland

    Nov 1, 2012, 00:00

  • PHP49 Down-Scheduling Medicines from Prescription to Over-the-Counter- Win-Win?

    Nov 1, 2012, 00:00

  • PHP108 Pattern of Antibiotics Usage in Malaysian Hajj Pilgrim

    Nov 1, 2012, 00:00

  • PSS19 Economic Evaluation of Ranibizumab for the Treatment of Macular Edema Secondary to Branch and Central Retinal Vein Occlusion in Canada

    Nov 1, 2012, 00:00

  • PIH47 Analysis of the Formulary Provision of Children in Ukraine

    Nov 1, 2012, 00:00

  • PMD38 The Cost Burden of Unexplained Syncope in Five European Countries- A Database Analysis

    Nov 1, 2012, 00:00

  • PCN7 A Systematic Review of the Heterogeneity of Treatment Effect in Ovarian Cancer (OC)—Are There Implications for Outcomes Research?

    Nov 1, 2012, 00:00

  • PHP6 Comparing the Effectivness of Different Educational Programs for Children on Appropriate Antibiotic Use

    Nov 1, 2012, 00:00

  • PMS22 Indirect Costs Associated With Rheumatoid Arthritis in Turkey

    Nov 1, 2012, 00:00

  • PRS11 The Short-Term Economic Impact of Three Childhood Preventive Health Programs in Israel

    Nov 1, 2012, 00:00

  • PCN79 Pharmacoeconomic Evaluation of Acute Myeloid Leukemia and MDS Syndromes (Intermediate and High Risk) Treatment With Azacitidine in the Russian Federation

    Nov 1, 2012, 00:00

  • PND23 Economic Burden of Illness for Persons With Spina Bifida (SB) in Germany

    Nov 1, 2012, 00:00

  • PRM128 Development of a Translation Evidence Tracking Tool to Comply With the FDA Review Requirements for the Translation of PRO Instruments

    Nov 1, 2012, 00:00

  • PCN77 Cost Effectiveness Analysis in the Veneto Region of Nab-Paclitaxel Monotherapy II Line Versus Conventional Paclitaxel in Patients With Breast Cancer and for Whom Anthracyclines are Not Indicated

    Nov 1, 2012, 00:00

  • PHP7 How Do Reimbursement Systems Encourage or Inhibit Adoption of Innovative Medical Devices in an Ambulatory Setting?

    Nov 1, 2012, 00:00

  • PRM76 A Treatment Sequence Approach for Modelling Crohn's Disease

    Nov 1, 2012, 00:00

  • PCV3 Prevalence, Associated Comorbidities and Treatment Patterns Among Chronic Kidney Disease Patients- An Analysis Using UK GPRD Data

    Nov 1, 2012, 00:00

  • PCV5 Comparison of Atrial Measurements and Estimations of Transmitral Regurgitation Using Three-Dimensional and Conventional Echocardiography in Dogs

    Nov 1, 2012, 00:00

  • PMD73 Quality of Life and Resource Use After Transcatheter Aortic Valve Implantation. Preliminary Results of an Observational Multicentre Study

    Nov 1, 2012, 00:00

  • PIN86 Clinical and Economic Burden of Community Acquired Pneumonia in 7 Countries. A Comparison With Invasive Pneumococcal Disease

    Nov 1, 2012, 00:00

  • PHP170 The Swiss Health Technology Assessment (HTA) Consensus- Guiding Principles

    Nov 1, 2012, 00:00

  • PCN30 Use of Mind Body Complementary Therapies (MBCTs) Among Malaysian Oncology Patients

    Nov 1, 2012, 00:00

  • PHP21 Does National Essential Medicine System Improve Rational Drug Use in Primary Health Care Facilities? An Empirical Study in Rural China

    Nov 1, 2012, 00:00

  • PDB26 Effect of Diabetes Disease Management Programs Based on Bundled Payment on Curative Health Care Costs in the Netherlands

    Nov 1, 2012, 00:00

  • PCV20 Possible Budget Impact of Internal Reference Pricing for Statins in Turkey

    Nov 1, 2012, 00:00

  • PHS76 An Infuenza Vaccination Policy Based on a Previous Year's Illness

    Nov 1, 2012, 00:00

  • PIN72 Cost-Effectiveness Analysis of Palivizumab With Risk Factors for Respiratory Syncytial Virus Prevention

    Nov 1, 2012, 00:00

  • CE3 Hyperbaric Oxygen Therapy for the Treatment Non-Neurological Soft Tissue Radiation Injuries- a Cost Effectiveness Analysis

    Nov 1, 2012, 00:00

  • PGI19 Costs and Effects of Dual Therapy With Pegylated Interferon and Ribavirin in Patients With Chronic Hepatitis C in Germany

    Nov 1, 2012, 00:00

  • PIH27 Cost Analysis of Neonatal and Pediatric Parenteral Nutrition in Belgium

    Nov 1, 2012, 00:00

  • PND28 Health Care Costs of Multiple Sclerosis in Germany

    Nov 1, 2012, 00:00

  • PMS74 Application of Data Visualization Tool- Treatment Patterns of Veteran Patients With Ankylosing Spondylitis Who Initiated Tumor Necrosis Factor Therapy

    Nov 1, 2012, 00:00

  • PMH22 Cost-Utility Analysis of Depot Atypical Antipsychotics for Chronic Schizophrenia in Croatia

    Nov 1, 2012, 00:00

  • PHS24 Cost of Traffic Accidents Related to Low Visibility Conditions- A Cost of Illness Study

    Nov 1, 2012, 00:00

  • PCN122 Pilot Survey to Estimate Willingness to Pay (WTP) for Prophylactic Granulocyte Colony-Stimulating Factors (G-CSFs) Among Previously Treated Breast Cancer Patients

    Nov 1, 2012, 00:00

  • PHP117 Study on the Health Insurance Coverage Among Poor and Disadvantaged Citizens

    Nov 1, 2012, 00:00

  • PHP131 Ensuring That Phase III Programs are Designed to Meet the Evolving HTA Requirements Across the EU5

    Nov 1, 2012, 00:00

  • PIN12 The Analysis for Inpatients Cost and Medical Insurance Coverage of Pneumonia in China, 2009

    Nov 1, 2012, 00:00

  • PND17 Comparing Cost of Therapeutic Plasma Exchange and Intravenous Immunoglobulin Infusion in Treating Guillain-BarrÉ Syndrome

    Nov 1, 2012, 00:00

  • PCV38 Economic Evaluation of Anticoagulant Strategies in Interventional Treatment of Acute Myocardial Infarction

    Nov 1, 2012, 00:00

  • DB3 Indirect Treatment Comparison (ITC) or Cost-Effectiveness Analysis (CEA)- a Study

    Nov 1, 2012, 00:00

  • PRM11 Evidence for Validity of a National Patient-Reported Survey in Japan- The Japan National Health and Wellness Survey

    Nov 1, 2012, 00:00

  • PCN136 Expenditures on Orphan Drugs in Canada, Europe (EU5 + Belgium, Sweden and the Netherlands) and Australia in 2009

    Nov 1, 2012, 00:00

  • PSY21 Cost-Effectiveness of Posaconazole Versus Fluconazole in the Prophylaxis of Invasive Fungal Infections in Patients With Graft-Versus-Host Disease (GVHD) in Turkey

    Nov 1, 2012, 00:00

  • PRM64 Bayesian MTC Models to Combine Evidence From Different Trial Designs

    Nov 1, 2012, 00:00

  • PCN26 Geographic Variation Associated with Colorectal Cancer Prevalence in the United States

    Nov 1, 2012, 00:00

  • PRM22 The Headroom Method of Early Economic Evaluation of Medical Devices- A Useful Tool for Device Developers?

    Nov 1, 2012, 00:00

  • PHP198 From Science to Servi The Ontario Patient Reported Outcomes of Symptoms and Toxicity (On-PROST) Research Unit

    Nov 1, 2012, 00:00

  • PUK14 Cost-Effectiveness Analysis of Mirabegron Versus Tolterodine Extended Release in the Treatment of Patients With Overactive Bladder in the United States

    Nov 1, 2012, 00:00

  • PMD21 Cost Comparison of Spinal Fusion Procedures With Grafton Mixed With Local Bone Compared to Iliac Crest Bone

    Nov 1, 2012, 00:00

  • PMS32 Cost-Efectiveness Analysis of Anti-Osteoporotic Therapy Among Korean Women With Postmenopausal Osteoporosis

    Nov 1, 2012, 00:00

  • PMD68 Cost-Effectiveness of Sacral Neuromodulation in the Treatment of Idiopathic Wet Refractory Overactive Bladder in Italy

    Nov 1, 2012, 00:00

  • PHS85 The Cost of Public Cancer Prevention in Alberta

    Nov 1, 2012, 00:00

  • PRS5 Cost Analysis of Childhood Asthma in Iran- A Cost Evaluation Based on Referral Center Data for Asthma Allergies

    Nov 1, 2012, 00:00

  • PCV84 Misdiagnosis and Mistreatment of ACE-Inhibitor Induced Cough Decreases Therapy Compliance

    Nov 1, 2012, 00:00

  • PIN4 Mixed-Treatment Comparison of the Efficacy and Safety of Antiretroviral Drugs Indicated for Treatment-Experienced HIV Patients

    Nov 1, 2012, 00:00

  • PMD58 Cost-Effectiveness Analysis of Leprosy Case Detection Methods in Northern Nigeria

    Nov 1, 2012, 00:00

  • PHP58 Data Disclosure an Ongoing Process Towards More Transparency

    Nov 1, 2012, 00:00

  • PIH26 Social Impact of Adalimumab in the Italian Perspective

    Nov 1, 2012, 00:00

  • PHS70 Health Related Quality of Life As Predictor of Death Among Patients With Heart Failure

    Nov 1, 2012, 00:00

  • PRM170 Optimizing Public Health Decision Over Time- A Dynamic Budget Optimization Model With Multiple Criteria Decision Making

    Nov 1, 2012, 00:00

  • PMS76 Patient Access to Biologics in Rheumatoid Arthritis- The Views of Health Care Stakeholders in Portugal

    Nov 1, 2012, 00:00

  • PDB70 Characteristics of Long-Acting Somatostatin (SSA) Use in Acromegaly in the Netherlands

    Nov 1, 2012, 00:00

  • PCN10 Examining the Use of Rescue Antiemetic Medication for Chemotherapy Induced Nausea and Vomiting in a Commercial Population

    Nov 1, 2012, 00:00

  • PHP41 Risk Management in Iranian Pharmaceutical Companies to Ensure Accessibility and Quality of Medicines

    Nov 1, 2012, 00:00

  • PSY15 Effectiveness of Fresh Frozen Plasma and Its Cost-Effectiveness in Iranian Acute Organophosphate Poisoning Patients

    Nov 1, 2012, 00:00

  • PMD3 Pre-Screening Tools- A Neglected Approach to Diagnose and Cut Cost Associated With Osteoporosis

    Nov 1, 2012, 00:00

  • PCN26 Health State Utilities for Relapsed/Refractory (Rel/Ref) Hodgkin'S Lymphoma (HL) and Systemic Anaplastic Large-Cell Lymphoma (sALCL)- Asian Pacific Country Data

    Nov 1, 2012, 00:00

  • PSU16 High Cost Patients for Cardiac Surgery and Hospital Quality in Turkey

    Nov 1, 2012, 00:00

  • PCV24 The Practical Assessment of Same-Day Discharge With Scheduled Trans-Radial Percutaneous Coronary Intervention

    Nov 1, 2012, 00:00

  • PMD47 Economic Evaluation of Reduced Futile 1st Line Therapy in Metastatic Renal Cell Carcinoma Patients Using Early Angiogenesis-Specific Imaging

    Nov 1, 2012, 00:00

  • PND57 A Measure of Carer Quality of Life in Parkinson's Disease (PDQ-Carer)- Development and Validation of a Summary Index Score

    Nov 1, 2012, 00:00

  • PHP81 Microeconomic Surplus or Convenience in Health Care- Applied Economic Theory in Health Care in Three European Countries

    Nov 1, 2012, 00:00

  • PHP109 Evaluation of the Use of Sedation for Adults Using Mechanical Ventilators in a Hospital in Taiwan

    Nov 1, 2012, 00:00

  • PCV42 Model Sensitivity Analysis of Venous Thromboembolism Prevention After Total Hip Replacement

    Nov 1, 2012, 00:00

  • PRS23 Pharmacoeconomic Analysis of Roflumilast for Treatment of Adult Patients With Severe-to-Very Severe Chronic Obstructive Pulmonary Disease (COPD)

    Nov 1, 2012, 00:00

  • PUK18 Cost-Effectiveness of Angiotensin-Converting Enzyme Inhibitors in Non-Diabetic Advanced Renal Disease – A Dutch Perspective

    Nov 1, 2012, 00:00

  • PGI22 Cost-Effectiveness Analysis of Dexlansoprazole for the Treatment of Erosive Esophagitis Compared to Conventional Proton Pump Inhibitors

    Nov 1, 2012, 00:00

  • PMS54 A Retrospective Cohort Study of Persistence Compliance to Treatment for Osteoporosis in Postmenopausal Women in Hungary

    Nov 1, 2012, 00:00

  • PDB9 Outcome of Fixed Dose Radioactive Iodine for the Treatment of Hyperthyroidism

    Nov 1, 2012, 00:00

  • PHS67 Rasch Model Validation of a Peer Relations Scale for People Treated for Psychoactive Substance Use Disorder

    Nov 1, 2012, 00:00

  • PR4 Trends in Pricing and Reimbursement Schemes From 1994-2011

    Nov 1, 2012, 00:00

  • PHS47 Cost-Utility Analysis of Rotigotine in Restless Legs Syndrome from the NHS Scotland Perspective

    Nov 1, 2012, 00:00

  • PMH49 Horizon Scanning of Molecular Imaging Methods in Psychiatric Disorders

    Nov 1, 2012, 00:00

  • PRM43 A Systematic Review on the Application of Cardiovascular Risk Prediction Models in Pharmacoeconomics, With a Focus on Primary Prevention

    Nov 1, 2012, 00:00

  • PHP19 Consumption of Drugs for Peptic Ulcer and Gastroesophageal Reflux Disease- Striking Differences Between Serbia and Norway

    Nov 1, 2012, 00:00

  • PCV14 Colesevelam for the Treatment of Hyperlipidemia- A Retrospective ‘Real-World' Analysis From an Integrated Health System

    Nov 1, 2012, 00:00

  • PRM34 Routine Data in HTA- Record Linkage in Austrias GAP-DRG Database

    Nov 1, 2012, 00:00

  • PRM139 Including Patients in Multiple Groups and Multiple Times in the Same Group in Longitudinal Observational Research- A Cystic Fibrosis Example

    Nov 1, 2012, 00:00

  • PCN158 Adherence to Human Epidermal Growth Factor Receptor-2 (HER2) Testing Adjuvant Trastuzumab Treatment Guidelines in a Canadian Province

    Nov 1, 2012, 00:00

  • PMH42 Assessing Impacts of Major Depressive Disorder (MDD) on Cognitive Function

    Nov 1, 2012, 00:00

  • PDB40 The Importance of HbA1C Evolution in Cost-Effectiveness Modeling of Type 2 Diabetes Mellitus (T2DM)

    Nov 1, 2012, 00:00

  • PCN149 Uncertainty Regarding NICE's End-of-Life Small Patient Population Criteria

    Nov 1, 2012, 00:00

  • PGI7 the Cost-Effectiveness of Rotavirus Vaccination in Guangzhou, China

    Nov 1, 2012, 00:00

  • PCN23 Cost-Effectiveness Analysis of Gefitinib for Lung Cancer- A Population Based Study

    Nov 1, 2012, 00:00

  • PDB30 The Pattern and Prescription Cost Among Diabetic Patients in the HO Municipal Hospital, Volta Region, Ghana

    Nov 1, 2012, 00:00

  • PCN28 A Feasibility Study on Applying Preference-Based Quality-of-Life Measures in Chronic Myeloid Leukemia Outpatients Treated With Imatinab in Taiwan

    Nov 1, 2012, 00:00

  • PHP178 Validity of Self-Reported Health Care Utilization- Towards a Research Consensus

    Nov 1, 2012, 00:00

  • PHP72 Making Money Work for Improvement of Patient Care- Success and Shortcomings of Pay-for-Performance Program in Taiwan

    Nov 1, 2012, 00:00

  • PDB4 HbA1C Reduction Associated With Initial Versus Sequential Combination Therapy With Pioglitazone (PIO) and Dipeptidyl Peptidase-4 Inhibitors (DPP4i) in Patients With Type 2 Diabetes Mellitus (T2DM)

    Nov 1, 2012, 00:00

  • PMS26 Assessment of the Burden of Rheumatoid Arthritis in Fran Analysis of a National Representative Claim Database

    Nov 1, 2012, 00:00

  • PCV66 Pharmacoeconomic Analysis of Azilsartan Medoxomil in Patients With Arterial Hypertension- Comparison With Valsartan, Telmisartan, Losartan and Irbesartan in the Mexican Context

    Nov 1, 2012, 00:00

  • PSU8 Budget Impact Analysis of Anti-Bacterial Suture Use in Appendectomy Procedures in Spain

    Nov 1, 2012, 00:00

  • PMD46 Economic Analysis of a Predictive Test for Taxane Response in Early Breast Cancer Patients in the UK

    Nov 1, 2012, 00:00

  • PMS71 Utilization of Duloxetine and Celecoxib in Osteoarthritis Patients

    Nov 1, 2012, 00:00

  • PIN28 Cost-of-Illness Analysis of Candidemia in Patients on the Intensive Care Unit

    Nov 1, 2012, 00:00

  • PRS6 Self-Reported Adherence to Inhaled Corticosteroids and Beliefs About Medicines in Asthma Patients- A Study From Emergency Room of a Chest Hospital in Delhi, India

    Nov 1, 2012, 00:00

  • PHP74 Submission of New Drug Reimbursement and Pricing Applications to National Health Insurance (NHI) of Taiwan, Meeting Outcomes of the Drug Benefit Committee

    Nov 1, 2012, 00:00

  • PHP174 Physical Activity Matters- The Associations Between Body Mass Index, Physical Activity and Health-Realted Quality-of-Life Trajectories Over 10 Years

    Nov 1, 2012, 00:00

  • PDB10 Clinical Survey to Assess Outcomes in Diabetes Patients Using Pen Needles of Different Lengths

    Nov 1, 2012, 00:00

  • PIH32 The Impact of Periods on Women's Quality of Life in Women Reporting a Problem

    Nov 1, 2012, 00:00

  • PRM59 Methods for Discounting in Economic Evaluation; An Empirical Comparison of Preferences in Money and Quality of Life

    Nov 1, 2012, 00:00

  • DB1 Assessing the Relationship Between the Effect of Glycemic Control and Avoided Symptomatic Hypoglycemia on Quality of Life in the Management of Type 2 Diabetes

    Nov 1, 2012, 00:00

  • PDB61 Research on the Incidence and Cost of Hypoglycemia Episode in Patients With Type 2 Diabetes Mellitus (T2DM)

    Nov 1, 2012, 00:00

  • PHP88 Workplace-Based Smoking Cessation Programmes – Identifying the Gaps Between Evidence and Practice

    Nov 1, 2012, 00:00

  • HC3 The Process of Updating the Items of National Health Insurance Benefits Schedule in Taiwan- is It Fair and Legitimate?

    Nov 1, 2012, 00:00

  • PCN155 Is Sale of Tobacco and Smoking Prevalence Predictors of Future Lung Cancer Incidence?

    Nov 1, 2012, 00:00

  • PRM156 How to Increase Patient Retention Rate During Their Participation in Longitudinal Studies

    Nov 1, 2012, 00:00

  • PSY8 Number Needed to Treat (NNT) and Cost Estimation to Achieve a Major Molecular Response (MMR) in Newly Diagnosed Chronic Myeloid Leukemia Patients in Greece

    Nov 1, 2012, 00:00

  • PRS4 Comparative Efficacy of Aclidinium Bromide 400 Mcg Bid Versus Tiotropium 18 Mcg and 5 Mcg QD as Maintenance Bronchodilator Treatment to Relieve Symptoms in Adult Patients With Chronic Obstructive Pulmonary Disease (COPD)- A Network Met ...

    Nov 1, 2012, 00:00

  • PGI27 Impact of Linaclotide Treatment on Work Productivity and Activity Impairment in Adults With Irritable Bowel Syndrome With Constipation

    Nov 1, 2012, 00:00

  • PSY11 The Effect of Serum Albumin Level With Kabiven for Nutrition Support in a Regional Hospital

    Nov 1, 2012, 00:00

  • PMD82 Implantable Cardioverter Defibrillator in Italy From 2000 to 2008- A Population-Based Analysis Using Health Administrative Databases

    Nov 1, 2012, 00:00

  • PHP32 Analyzing the Utilities of Fluoroquinolones at a Regional Teaching Hospital of Southern Taiwan

    Nov 1, 2012, 00:00

  • PHP30 The Utilization and Expenditure of Reimbursed Digestive Enzyme Agents in Taiwan

    Nov 1, 2012, 00:00

  • PHP147 Early Access Programmes (EAPs)- Review of the European System

    Nov 1, 2012, 00:00

  • PHP15 The Impact of Orphan Drug Incentives on Innovation and Pricing in Niche Therapeutic Markets- A Systematic Review of the Literature

    Nov 1, 2012, 00:00

  • PDB3 How Different Were They? A Treatment Pattern Analysis of United States Patients With Type 2 Diabetes Mellitus (T2DM) Initiating Injectable Therapy

    Nov 1, 2012, 00:00

  • PSU5 Bariatric Surgery From the Perspective of Brazilian National Health System (SUS)

    Nov 1, 2012, 00:00

  • PR1 Does Medication Adherence Correlate With Health-Related Quality of Life? Findings From a Descriptive Analysis

    Nov 1, 2012, 00:00

  • PMH25 An Assessement of the Cost-Effectiveness of Escitalopram Versus Multiple Comparators as First Line Antidepressant in Patients With Major Depressive Disorder (MDD) in Belgium

    Nov 1, 2012, 00:00

  • PMH48 Public Beliefs and Attitudes About Schizophrenia, Major Depression and Psychotropic Medication

    Nov 1, 2012, 00:00

  • ME1 Comparison of the Measurement Properties Between the 5-Level EuroQoL Group's 5-Dimension (EQ-5D-5L) Questionnaire and the Functional Assessment of Cancer Therapy – Breast (FACT-B) in Asian Breast Cancer Patients

    Nov 1, 2012, 00:00

  • PMH10 Patient Persistence With Buprenorhine/Naloxone Film and Tablet Formulations in the Treatment of Opioid Dependence in the United States- Results From a Large Privately Insured Retrospective Database

    Nov 1, 2012, 00:00

  • PCV24 Economic Analysis of Bemiparin and Enoxaparin Used for Thrombosis and Embolism Prevention in Orthopedic Patients in Russia

    Nov 1, 2012, 00:00

  • Dementia Care in the General Practice Setting- A Cluster Randomized Trial on the Effectiveness and Cost Impact of Three Management Strategies

    Sep 1, 2012, 00:00

  • State-Transition Modeling- A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-3

    Sep 1, 2012, 00:00

  • Using Health State Utility Values in Models Exploring the Cost-Effectiveness of Health Technologies

    Sep 1, 2012, 00:00

  • The Utility Assessment Method Order Influences Measurement of Parents' Risk Attitude

    Sep 1, 2012, 00:00

  • A Comparison of Preferences of Targeted Therapy for Metastatic Renal Cell Carcinoma between the Patient Group and Health Care Professional Group in South Korea

    Sep 1, 2012, 00:00

  • Instructions for Authors

    Sep 1, 2012, 00:00

  • Cost-Effectiveness Analysis of Antiviral Treatments for HBeAg-Positive Chronic Hepatitis B in Canada

    Sep 1, 2012, 00:00

  • An Evaluation Framework for Funding Drugs for Rare Diseases

    Sep 1, 2012, 00:00

  • Conceptualizing a Model- A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-2

    Sep 1, 2012, 00:00

  • Effect of Acute Bleeding on Daily Quality of Life Assessments in Patients with Congenital Hemophilia with Inhibitors and Their Families- Observations from the Dosing Observational Study in Hemophilia

    Sep 1, 2012, 00:00

  • Modeling Good Research Practices—Overview- A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-1

    Sep 1, 2012, 00:00

  • Relative Effectiveness Assessment of Pharmaceuticals- Similarities and Differences in 29 Jurisdictions

    Sep 1, 2012, 00:00

  • Costs of Adverse Drug Events in German Hospitals—A Microcosting Study

    Sep 1, 2012, 00:00

  • Evaluating New Health Technologies and Disease Burden in Developed Countries

    Sep 1, 2012, 00:00

  • Dynamic Transmission Modeling- A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-5

    Sep 1, 2012, 00:00

  • Model Parameter Estimation and Uncertainty- A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-6

    Sep 1, 2012, 00:00

  • Letter from the Editors

    Sep 1, 2012, 00:00

  • Model Transparency and Validation- A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-7

    Sep 1, 2012, 00:00

  • Multicriteria Decision Analysis for Including Health Interventions in the Universal Health Coverage Benefit Package in Thailand

    Sep 1, 2012, 00:00

  • Creating Models That Meet Decision Makers' Needs- A US Payer Perspective

    Sep 1, 2012, 00:00

  • Matching-Adjusted Indirect Comparisons- A New Tool for Timely Comparative Effectiveness Research

    Sep 1, 2012, 00:00

  • Innovation and the Burden of Disease—Reply to Letter to the Editor by Catalá-López et al

    Sep 1, 2012, 00:00

  • Quality-of-Life Impact of Sentinel Lymph Node Biopsy Versus Axillary Lymph Node Dissection in Breast Cancer Patients

    Sep 1, 2012, 00:00

  • FDA Actions Against Health Economic Promotions, 2002–2011

    Sep 1, 2012, 00:00

  • Copyright/Subscription

    Sep 1, 2012, 00:00

  • Table of Contents

    Sep 1, 2012, 00:00

  • Orthopaedic Trauma Care in Haiti- A Cost-Effectiveness Analysis of an Innovative Surgical Residency Program

    Sep 1, 2012, 00:00

  • Modeling using Discrete Event Simulation- A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-4

    Sep 1, 2012, 00:00

  • Development of a Decision-Analytic Model for the Application of STR-Based Provenance Testing of Transrectal Prostate Biopsy Specimens

    Sep 1, 2012, 00:00

  • The Inclusion of Informal Care in Applied Economic Evaluation- A Review

    Sep 1, 2012, 00:00

  • Cost-Effectiveness of Truncated Therapy for Hepatitis C Based on Rapid Virologic Response

    Sep 1, 2012, 00:00

  • The View of a Model user on the ISPOR-SMDM Modeling Good Research Task Force Report

    Sep 1, 2012, 00:00

  • Editorial Board

    Sep 1, 2012, 00:00

  • How Do Insured Perceive Their Financial Security in the Event of Illness?—A Panel Data Analysis for Germany

    Jul 1, 2012, 00:00

  • Combining Individual-Level Discrete Choice Experiment Estimates and Costs to Inform Health Care Management Decisions about Customized Care- The Case of Follow-Up Strategies after Breast Cancer Treatment

    Jul 1, 2012, 00:00

  • Cost-Effectiveness of Expanded Newborn Screening in Texas

    Jul 1, 2012, 00:00

  • Inverse Probability Weighted Least Squares Regression in the Analysis of Time-Censored Cost Data- An Evaluation of the Approach Using SEER-Medicare

    Jul 1, 2012, 00:00

  • Instructions for Authors

    Jul 1, 2012, 00:00

  • Modeling the Risks and Benefits of Depression Treatment for Children and Young Adults

    Jul 1, 2012, 00:00

  • Erratum

    Jul 1, 2012, 00:00

  • Does Responsibility Affect the Public's Valuation of Health Care Interventions? A Relative Valuation Approach to Health Care Safety

    Jul 1, 2012, 00:00

  • The Maximum Willingness to Pay for Smoking Cessation Method among Adult Smokers in Mexico

    Jul 1, 2012, 00:00

  • Financial Risk-Sharing in Updating the National List of Health Services in Israel- Stakeholders' Perceived Interests

    Jul 1, 2012, 00:00

  • Valuing the Extended Role of Prescribing Pharmacist in General Practice- Results from a Discrete Choice Experiment

    Jul 1, 2012, 00:00

  • The Clinical and Economic Burden of Poor Adherence and Persistence with Osteoporosis Medications in Ireland

    Jul 1, 2012, 00:00

  • Editorial Board

    Jul 1, 2012, 00:00

  • Economic Evaluation and the Jordan Rational Drug List- An Exploratory Study of National-Level Priority Setting

    Jul 1, 2012, 00:00

  • Switching from Originator Brand Medicines to Generic Equivalents in Selected Developing Countries- How Much Could Be Saved?

    Jul 1, 2012, 00:00

  • Whose Values in Health? An Empirical Comparison of the Application of Adolescent and Adult Values for the CHU-9D and AQOL-6D in the Australian Adolescent General Population

    Jul 1, 2012, 00:00

  • Development of a Database of Instruments for Resource-Use Measurement- Purpose, Feasibility, and Design

    Jul 1, 2012, 00:00

  • Improving the Measurement of QALYs in Dementia- Some Important Considerations

    Jul 1, 2012, 00:00

  • Cost-Effectiveness Analysis of the Bivalent Compared with the Quadrivalent Human Papillomavirus Vaccines in Taiwan

    Jul 1, 2012, 00:00

  • Approach to Fixing the Discrepancy Found in the Wu et al. FACT-P to EQ-5D Questionnaire Mapping Algorithm

    Jul 1, 2012, 00:00

  • Approach to Fixing the Discrepancy Found in the Wu et al. FACT-P to EQ5D Mapping Algorithm—Reply to Letter to the Editor by David Cella, Irina Proskorovsky, and Feng Pan

    Jul 1, 2012, 00:00

  • Interim Scoring for the EQ-5D-5L- Mapping the EQ-5D-5L to EQ-5D-3L Value Sets

    Jul 1, 2012, 00:00

  • Bendamustine Versus Chlorambucil for the First-Line Treatment of Chronic Lymphocytic Leukemia in England and Wales- A Cost-Utility Analysis

    Jul 1, 2012, 00:00

  • Validation of the UFS-QOL-Hysterectomy Questionnaire- Modifying an Existing Measure for Comparative Effectiveness Research

    Jul 1, 2012, 00:00

  • Time Trade-Off and Ranking Exercises Are Sensitive to Different Dimensions of EQ-5D Health States

    Jul 1, 2012, 00:00

  • Deriving Input Parameters for Cost-Effectiveness Modeling- Taxonomy of Data Types and Approaches to Their Statistical Synthesis

    Jul 1, 2012, 00:00

  • Cost-Effectiveness of Sensor-Augmented Pump Therapy in Adults with Type 1 Diabetes in the United States

    Jul 1, 2012, 00:00

  • Willingness to Pay for Prostate Cancer Treatment among Patients and Their Family Members at 1 Year After Diagnosis

    Jul 1, 2012, 00:00

  • Copyright/Subscription

    Jul 1, 2012, 00:00

  • Table of Contents

    Jul 1, 2012, 00:00

  • Heterogeneous Effects of Health Insurance on Out-of-Pocket Expenditure on Medicines in Mexico

    Jul 1, 2012, 00:00

  • Response to Comments on Mulhern et al., “Improving the Measurement of QALYs in Dementia- Developing Patient- and Carer-Reported Health State Classification Systems Using Rasch Analysis”

    Jul 1, 2012, 00:00

  • CE1 Cost Effectiveness Trends of High Budget Impact Drugs (2006-2012)

    Jun 1, 2012, 00:00

  • PIN11 Costs of Adverse Events Among Patients With Human Immunodeficiency Virus Treated With Non-Nucleoside Reverse Transcriptase Inhibitors

    Jun 1, 2012, 00:00

  • PMH66 Growth in Antidepressant Use in 10 Countries in the Last Decade

    Jun 1, 2012, 00:00

  • PHP35 Determinants of Participation in Mammography Screening in Taiwan

    Jun 1, 2012, 00:00

  • PHP15 What Price do we Pay for Repurposing Medicines for Rare Diseases?

    Jun 1, 2012, 00:00

  • PIN46 The Effect of Anemia on Health Status and Work Productivity Among Treated Hepatitis C Patients

    Jun 1, 2012, 00:00

  • PDB31 Targeted Cost Saving Strategies in Diabetes Prevention Using Risk Stratification

    Jun 1, 2012, 00:00

  • PDB98 Treatment Patterns and Treatment Restrictions of Patients With Type II Diabetes Receving Care From Home Health Care Agencies, Skilled Nursing Facilities, and Veterans Affairs Settings in the United States

    Jun 1, 2012, 00:00

  • PMS63 Treatment with Infliximab Improves the Quality of Life of Rheumatoid Arthritis Patients in China

    Jun 1, 2012, 00:00

  • PSY3 Adverse Events Associated With Anti-TNF-Alpha- Agents- A Pharmacovigilance Study

    Jun 1, 2012, 00:00

  • PCN73 Economic Evaluation of Antithrombotic Therapies in Patients With Cancer in Mexico

    Jun 1, 2012, 00:00

  • PHP47 The Economic Impact of a Cost-Effectiveness Threshold on the Innovative Drug Expenditure in Qatar

    Jun 1, 2012, 00:00

  • PIH77 Annual Overall and Epilepsy-Related Health Care Utilization in Adult Epilepsy Patients in the United States

    Jun 1, 2012, 00:00

  • PSY62 Predictors of Pain Medication Selection Among Patients Diagnosed With Chronic Lower Back Pain

    Jun 1, 2012, 00:00

  • PMH60 Health-Related Quality of Life (HRQOL) among Survivors 8 Months and 3 Years After Sichuan 2008 Earthquake in China

    Jun 1, 2012, 00:00

  • PIN49 Patient Reported Quality of Life Following Antiretroviral Therapy in a Nigerian Hospital

    Jun 1, 2012, 00:00

  • PDB55 Estimating the Cost-Effectiveness of Premixed Analog Insulin Versus Long Acting Analog Basal Insulin and Premixed Human Insulin in the Management of Type 2 Diabetes- A Long Term Analysis in the United Kingdom (UK)

    Jun 1, 2012, 00:00

  • PIN4 Efficacy and Safety of the Combination Tenofovir (TDF)/Emtricitabina (FTC) + Efavirenz (EFV) in Treatment of Naive Adult Patients With HIV-1 Infection- A Systematic Review

    Jun 1, 2012, 00:00

  • PSS30 Dosing Patterns and Health Care Provider Interactions for Psoriasis Patients Treated with Ustekinumab

    Jun 1, 2012, 00:00

  • RM3 Antipsychotic Use and Risk of All-Cause Mortality in Elderly Dual Eligible Beneficiaries

    Jun 1, 2012, 00:00

  • PMD39 Projection of Health Economics Benefits of Continuous Glucose Monitoring Versus Self Monitoring of Blood Glucose in Type 1 Diabetes, in Sweden

    Jun 1, 2012, 00:00

  • PMD29 The Cost-Effectiveness of Diagnostic Sigmoidoscopy Before Colonoscopy in 40 to 49-Year-Old Symptomatic Patients

    Jun 1, 2012, 00:00

  • PIN65 The Changing Nature of HIV in the Past 5 Years- Implications for Economic Modeling

    Jun 1, 2012, 00:00

  • PDB107 Patient Characteristics and Outcomes Among Individuals With Type 2 Diabetes- A Comparison Based Upon Adherence

    Jun 1, 2012, 00:00

  • PSY60 Pain Management- Observation and Side Effects

    Jun 1, 2012, 00:00

  • PSU20 Hospital Costs of Gastrointestinal Strictures Following Laparoscopic Bariatric Surgery Procedures Utilizing Circular Staplers

    Jun 1, 2012, 00:00

  • PIN61 Bacteriology and Inappropriate Empiric Therapy in Mixed Complicated Skin and Skin Structure Infections

    Jun 1, 2012, 00:00

  • PRM27 A Method of Projecting Future Co-Morbidity Prevalence and Health Service Demand in the United Kingdom Population Using the Health Improvement Network (THIN)

    Jun 1, 2012, 00:00

  • PCV85 Effect of Secondary Preventive Measures on the Health Related Quality of Life of Myocardial Infarction Patients

    Jun 1, 2012, 00:00

  • PMH39 Impact of Adherence to Anti-Depressant Medication on Short-Term Disability Costs in an Employer Population

    Jun 1, 2012, 00:00

  • PHP112 Investment and Disinvestment of Health Technologies- The Need for Two Cost-Effectiveness Thresholds

    Jun 1, 2012, 00:00

  • PRM10 The Behavioral Economics of the Minimally Important Difference

    Jun 1, 2012, 00:00

  • PMD52 Inpatient Reimbursement Landscape for Medical Device and Diagnostics in Developed Markets

    Jun 1, 2012, 00:00

  • PSU40 Six Years of Cardiac Database Management- The Impact on Clinical Practice

    Jun 1, 2012, 00:00

  • PMS10 The Cost of Hospitalisation for Knee Osteoarthritis in France in 2010

    Jun 1, 2012, 00:00

  • PSY37 A UK Based Cost-Effectiveness Analysis of Dasatinib (Sprycel) 100mg Daily Compared to Imatinib (Glivec) 600/800mg Daily as Therapy for Imatinib Failing Chronic Myeloid Leukemia (CML)

    Jun 1, 2012, 00:00

  • PDB52 Cost-Effectiveness of Renal Screening Strategies and Treatment Options for Patients With Type 1 Diabetes in the United Kingdom

    Jun 1, 2012, 00:00

  • PCV11 Patient Characteristics and Comorbidities of Patients with Atrial Fibrillation in Japan

    Jun 1, 2012, 00:00

  • PSU2 Relationship Between Medical Co-Morbidities and Hospitalization Following Elective Total Knee Arthroplasty (TKA)

    Jun 1, 2012, 00:00

  • PCN129 Association Between BMI and Personal Health and Screening History, Preventive Care, and Wellness Behaviors Among Participants in a Mobile Mammography Program

    Jun 1, 2012, 00:00

  • PMS2 The Efficacy of Duloxetine, Non-Steroidal Anti-Inflammatory Drugs, and Opioids in Osteoarthritis- A Meta-Analysis

    Jun 1, 2012, 00:00

  • PIH39 Eliciting Preferences to the EQ-5D-5L Health States- Discrete Choice Experiment or Multiprofile Case of Best-Worst Scaling

    Jun 1, 2012, 00:00

  • PCN18 Assessing the Clinical and Economic Burden of Veteran Breast Cancer Patients in the United States

    Jun 1, 2012, 00:00

  • PMS66 Satisfaction with and Preference for Golimumab and its Auto-Injector among Rheumatoid Arthritis Patients Switched from Adalimumab or Etanercept

    Jun 1, 2012, 00:00

  • PRM23 Proqolid Database- Where Are We Ten Years After Its Launch?

    Jun 1, 2012, 00:00

  • PMS41 Persistency with Subcutaneous Anti-TNF Therapy for Treatment of Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis Patients

    Jun 1, 2012, 00:00

  • PDB66 Instruments Measuring Treatment Adherence and Compliance in Diabetes Mellitus- a Literature Review

    Jun 1, 2012, 00:00

  • PDB94 The Trend of Influenza and Pneumococcal Vaccination Among Adults With Diabetes in the United States, 2006-2010

    Jun 1, 2012, 00:00

  • PMH10 Functional Outcome Measures- A Powerful Tool to Demonstrate Treatment Success in Schizophrenia

    Jun 1, 2012, 00:00

  • PCV107 Impact of Medication Therapy Management (MTM) on Improving Diabetes Care- A Difference-in-Differences Approach

    Jun 1, 2012, 00:00

  • PSY39 Dosing and Refill Compliance in Ankylosing Spondylitis Patients Treated With Golimumab

    Jun 1, 2012, 00:00

  • PRS49 All-Cause 30-Day Readmissions for Matched Inpatients with Copd Receiving Nebulized Short-Acting or Long-Acting Beta Agonists

    Jun 1, 2012, 00:00

  • PCN32 Comparing Health Care Resource Use, Costs and Adverse Events Among Lung Cancer Patients Treated With Standard Chemotherapy With or Without an Angiogenesis Inhibitor- A Retrospective Database Study

    Jun 1, 2012, 00:00

  • PND3 Indirect Treatment Comparison (ITC) Analysis of Therapies That are Often Considered for Treatment-Experienced Patients With Relapsing-Remitting Multiple Sclerosis

    Jun 1, 2012, 00:00

  • MA2 Comparison of Health Care Costs for Crohn's Disease Patients Who are Adherent Versus Intermittently Adherent with Infliximab Therapy

    Jun 1, 2012, 00:00

  • PCN61 Cost-Effectiveness of Sunitinib + Best Supportive Care for the Treatment of Unresectable Pancreatic Neuroendocrine Tumors in Mexico

    Jun 1, 2012, 00:00

  • PCN16 Design and Rationale of the Multiple Myeloma Preamble Study- A Prospective, Non-Interventional, Multi-Center Cohort Study

    Jun 1, 2012, 00:00

  • PCV121 Using International HTA Guidelines to Inform UK Health Care Decision-Making- A Case Study of Ticagrelor in Combination with Low-Dose Aspirin for the Treatment of Acute Coronary Syndromes

    Jun 1, 2012, 00:00

  • PMS80 Modeling Future Prevalence of Arthritis and Demand for Pharmaceuticals

    Jun 1, 2012, 00:00

  • PRS5 Co-Morbid Depression and Its Impact on Health Care Expenditure among Individuals with Asthma

    Jun 1, 2012, 00:00

  • PMH19 Combination Utilization Patterns and Treatment Predictors in ADHD in a Commercially Insured Population

    Jun 1, 2012, 00:00

  • PIH60 Speaking of PROs- Towards Finding a Common PROse for Improving Communication about Health-Related Quality of Life Concepts

    Jun 1, 2012, 00:00

  • PUK16 Reduced Use of Erythropoiesis-Stimulating Agents and Intravenous Iron with Use of the Phosphate Binder Ferric Citrate- a Facility-Level Cost-Offset Model Under the Medicare Bundle

    Jun 1, 2012, 00:00

  • PCN31 Economic Evaluation of Azacitidine for the Treatment of Myelodysplastic Syndromes (MDS) in the Brazilian Public Health Care System (SUS)

    Jun 1, 2012, 00:00

  • PHP30 The Bittersweet Success of Orphan Drugs

    Jun 1, 2012, 00:00

  • PCV76 Patient Factors Affecting Non-Adherence to Anticoagulation Therapy in an Inner-City Underserved Minority Population

    Jun 1, 2012, 00:00

  • PDB42 Health Care Resources Utilization and Cost for Hypoglycemia and Metabolic Acidosis in Type Ii Diabetes- an Analysis of the Ramq Database

    Jun 1, 2012, 00:00

  • CN4 Total Health Care Costs for Colorectal Cancer Patients Following Metastatic Diagnosis

    Jun 1, 2012, 00:00

  • PND45 Mobility Impairment and Health-Related Quality of Life in Multiple Sclerosis Patients

    Jun 1, 2012, 00:00

  • PDB106 Impact of Long Acting Insulin Agents on Health Related Quality of Life (HRQoL), Health Care Expenditures and Utilization

    Jun 1, 2012, 00:00

  • PHP61 The Financial Impacts of Pharmacist Intervention in Inpatient Department of a Local Hospital in Taiwan

    Jun 1, 2012, 00:00

  • PIN35 Decision Analysis Model Evaluating the Cost-Effectiveness of Fidaxomicin and Vancomycin in the Treatment of Clostridium Difficile Infection (CDI) from a Hospital Perspective

    Jun 1, 2012, 00:00

  • PIH5 Systematic Review Comparing the Efficacy of the 5-Alpha Reductase Inhibitors (5-Aris) Dutasteride and Finasteride in the Treatment of Benign Prostatic Hyperplasia (BPH)

    Jun 1, 2012, 00:00

  • PCV116 Hospital Readmissions in Patients with Heart Failure in Arizona

    Jun 1, 2012, 00:00

  • PMH53 Measuring Real World Outcomes by Incorporating PRO Data Collection into Patient Access Support Programs

    Jun 1, 2012, 00:00

  • PHP38 Out-of-Pocket Drug Expenditure Among Users of the Ambulatory Care Services at the Mexican Institute of Social Security (IMSS)

    Jun 1, 2012, 00:00

  • PCN108 Review of the Content Validity of the Patient Reported Outcome Measures Used in Patients With Brain Metastases

    Jun 1, 2012, 00:00

  • PDB41 Impact of Sustained Hemoglobin A1C Control on Health Care Costs Among Patients With Diabetes in Hawaii

    Jun 1, 2012, 00:00

  • PRS3 Inhaled Anticholinergics and Risk of All-Cause Mortality in Patients with Chronic Obstructive Pulmonary Disease- a Systematic Review and Meta Analysis of Randomized Controlled Trials

    Jun 1, 2012, 00:00

  • PMH36 An Economic Evaluation of Screening for Dementia in South Korea

    Jun 1, 2012, 00:00

  • PCN17 Chemotherapy Treatment and Impact of Second Line Chemotherapy on Overall Survival (OS) in Metastatic Castrate Resistant Prostate Cancer (CRPC) in Southeastern Oncology Community Practice

    Jun 1, 2012, 00:00

  • PND44 Assessing Variations in Transitions in Employment in Relapsing-Remitting Multiple Sclerosis Patients Treated With Either Laquinimod, Interferon Beta 1-a or Placebo- Expoloratory Evidence From the United States Substudy of Bravo

    Jun 1, 2012, 00:00

  • PRS30 Inhaled Corticosteroid and Long-Acting Beta-Agonist Medication Compliance in Patients with Moderate and Severe Asthma

    Jun 1, 2012, 00:00

  • PIN12 Cost Analysis of Rilpivirine Versus Efavirenz for Treatment of Human Immunodeficiency Virus (HIV)

    Jun 1, 2012, 00:00

  • PCN99 Preference-Based Estimates of the Health Utility Impacts of Breast Cancer in Women Ages 18-44 in the United States

    Jun 1, 2012, 00:00

  • PND43 Development of the Satisfaction with Injection Experience Questionnaire for Patients with Multiple Sclerosis

    Jun 1, 2012, 00:00

  • PRS1 Assessing the Association of Omalizumab Use and Arteriothrombotic Events Through Spontaneous Adverse Event Reporting

    Jun 1, 2012, 00:00

  • PDB71 Health Related Quality of Life in Kidney Transplant Patients With Diabetes

    Jun 1, 2012, 00:00

  • PMH59 Burden of Disease in Patients with Diagnosed Depression in Brazil- Results from 2011 National Health and Wellness Survey (NHWS)

    Jun 1, 2012, 00:00

  • PIH26 Public Funding for Infertility Treatments in Canada- Eligibility and Demand for IVF in Canada

    Jun 1, 2012, 00:00

  • PND11 Cost of Cervical Dystonia in the United States

    Jun 1, 2012, 00:00

  • PHP86 Analysis of Factors Influencing Drugs Prescription Decision Making in Ukraine

    Jun 1, 2012, 00:00

  • PUK1 the Effect of Coadminstration of Nicotinamide and Calcium-Based Phosphate Binder on Hyperphophatemia in Patients Undergoing Hemodialysis

    Jun 1, 2012, 00:00

  • PND51 The Impact of Patient Sex on Patterns of Diagnosis and Treatment Among Patients With Parkinson's Disease

    Jun 1, 2012, 00:00

  • PCV43 Economic Burden of Venous Thromboembolism in Orthopedic Surgery Patients in Colombia

    Jun 1, 2012, 00:00

  • PIH48 Developing an Instrument to Assess Product Preference for Testosterone Replacement Therapy

    Jun 1, 2012, 00:00

  • PCV42 Cost Analysis of Venous Thromboembolism Prophylaxis After Total Knee Replacement and Total Hip Replacement

    Jun 1, 2012, 00:00

  • PDB99 Underused Diabetes Monitoring Services and Out-of-Pocket Health Care Expenses Share Among Americans With Diabetes Mellitus

    Jun 1, 2012, 00:00

  • PSY4 Prevalence of Autoimmune Diseases and Other Comorbidities in Patients With Psoriasis in the United States

    Jun 1, 2012, 00:00

  • PND29 Resource Utilization and Caregiver Burden Associated With Fragile X Syndrome in the United States

    Jun 1, 2012, 00:00

  • PSY56 Impact of Early Versus Late Systemic Lupus Erythematosus (SLE) Diagnosis on Clinical and Economic Outcomes

    Jun 1, 2012, 00:00

  • PHP23 Savings Through the Increased Use of Generic Medicines by Elderly- The Belgian Case

    Jun 1, 2012, 00:00

  • PRS38 A Survey of Asthma Management Programs in Managed Care Organizations

    Jun 1, 2012, 00:00

  • PMD14 Estimating the Economic Burden of Atrial Fibrillation in Selected Developing Countries

    Jun 1, 2012, 00:00

  • PHP55 Evidence Based Advertisement- Where is the Pharmacoeconomic and Humanistic Outcomes Research Evidence?

    Jun 1, 2012, 00:00

  • PSU10 Comparative Cost-Effectiveness Analysis of Coflex Interlaminar Stabilization Versus Posterolateral Fusion for Lumbar Stenosis and Low-Grade Spondylolisthesis

    Jun 1, 2012, 00:00

  • PSU29 The Importance of Medical Appointments After Roux-en-Y Gastric Bypass in Morbid Obese Patients- Association Between Adherence to Medical Follow-Up Visits and the Bariatric Analysis and Reporting Outcome System (BAROS) Score Based on a ...

    Jun 1, 2012, 00:00

  • PMS14 Health Care Costs and Opioid Use among Patients with Osteoarthritis Initiating Duloxetine Versus Other Treatments

    Jun 1, 2012, 00:00

  • PMS78 Analyzing the Difference in Health Care Costs of Rheumatoid Arthritis Patients Switching or Dose Escalating Anti-TNF Biologics Using Combined Propensity Score Matching and Multivariate Regression Model

    Jun 1, 2012, 00:00

  • PRS42 Disparities In Health Care Resources Use among Asthma Patients in Brazil

    Jun 1, 2012, 00:00

  • PCV90 The Quality of Anticoagulation Therapy in Patients with Atrial Fibrillation

    Jun 1, 2012, 00:00

  • PHP83 Community Health Workers- A Literature Review in Some Countries of South America

    Jun 1, 2012, 00:00

  • PCN69 Cost-Effectiveness Analysis of Aromatase Inhibitors and Tamoxifen As an Adjuvant Therapy in Postmenopausal Women with Early-Stage Hormone Receptor Positive Breast Cancer

    Jun 1, 2012, 00:00

  • PCN55 Total Health Care Expenditures in Newly Diagnosed Colorectal Cancer Adults With Private Insurance in a Claims Database in the United States

    Jun 1, 2012, 00:00

  • PSU26 Cost-Utility Analysis of Bariatric Surgery for the Treatment of Obese Patients in South Korea

    Jun 1, 2012, 00:00

  • PRM49 How to Present the Probability of Being the Best Treatment in the Context of a Bayesian Network Meta-Analysis of Parametric Survival Curves?

    Jun 1, 2012, 00:00

  • PRS35 Accessibility of the Copd Assessment Test (Cat) on Electronic Platforms for Wider Use among People Diagnosed with Copd

    Jun 1, 2012, 00:00

  • PCV73 Impact of Calendar Blister Packaging (CBP) on Adherence with Antihypertensive Medications in Older Adults Treated for Dementia

    Jun 1, 2012, 00:00

  • PMH57 Cross-Country Comparisons of Adults with Major Depressive Disorder

    Jun 1, 2012, 00:00

  • PCV124 Combining Electronic Health Records and Patient-Reported Information in the UK- Preliminary Results from Wasps (Wales Sail + Pro Study)

    Jun 1, 2012, 00:00

  • PGI20 Pre- to Post-Diagnosis Increase in Utilization and Costs of Chronic-Use Medications and Other Medical Resources in Managed Care Enrollees with Diverticulitis

    Jun 1, 2012, 00:00

  • PUK34 Validation of ICD-9 Codes for the Identification of Patients with Stage 3-5 Chronic Kidney Disease in Administrative Claims Data

    Jun 1, 2012, 00:00

  • PND54 Short and Long-Term Variations in All Cause Health Care Utilization and Costs for Newly Diagnosed Multiple Sclerosis Patients Enrolled in Either Medicaid HMO or Commercial HMO

    Jun 1, 2012, 00:00

  • PHP101 Legal Impact of Pharmaceutical Pricing in the German Statutory Health Insurance System

    Jun 1, 2012, 00:00

  • PDB11 Health Outcomes of Initiating Basal Analog Insulin via Disposable Pens Among Patients With Type-2 Diabetes in a National Managed Care Plan in the United States

    Jun 1, 2012, 00:00

  • PMD57 New Approaches for Graphing Probabilistic Patient-Relevant Health Outcomes- The Case of Renal Denervation for Resistant Hypertension

    Jun 1, 2012, 00:00

  • CE4 A Framework for Stakeholder Engagement in Comparative Effectiveness Research

    Jun 1, 2012, 00:00

  • PCN85 Economic Evaluation in the Treatment of Advanced and/or Metastatic Gastric Cancer From the Perspective of the Public Health System in Mexico

    Jun 1, 2012, 00:00

  • PDB91 Systematic Review of Diabetes Disease Management Inverventions

    Jun 1, 2012, 00:00

  • PHP2 Value of Patient Submissions in Drug Coverage Processes

    Jun 1, 2012, 00:00

  • PIN60 Epidemiology of Pneumococcal Diseases in Mexico in Patients Older Than 50 Years Old

    Jun 1, 2012, 00:00

  • PMS68 Clinical and Economic Outcomes Associated with Teriparatide Adherence in Medicare Part D Recipients- A Retrospective Cohort Study

    Jun 1, 2012, 00:00

  • PGI23 Cost Effectiveness of Retreatment of Patients with Chronic Hepatitis C (Chc) Who Do Not Respond to Peginterferon Alpha and Ribavirin for 48 Weeks Vs. Peginterferon Alfa and Ribavirin for 72 Weeks

    Jun 1, 2012, 00:00

  • PDB8 the Effect of Dapagliflozin on Hedis Performance Measures of Hba1C in Patients with Type 2 Diabetes Mellitus

    Jun 1, 2012, 00:00

  • PSU16 Retrospective Analysis of Cost Outcomes for Patients Receiving Infuse Bone Graft (rhBMP-2) or Actifuse Bone Graft Substitute (Si-CaP) During Posterolateral Spinal Fusion

    Jun 1, 2012, 00:00

  • PHP51 Review of the Clinical and Economic Value in the Use of Hybrid Operating Room

    Jun 1, 2012, 00:00

  • PHP62 Prescribing Evaluation Program in South Korea

    Jun 1, 2012, 00:00

  • PIH85 The Disability and Qol with the Elderly

    Jun 1, 2012, 00:00

  • PHP43 Financing Health Care in Nepal

    Jun 1, 2012, 00:00

  • PCN156 Development and Validation of a Patient-Reported Questionnaire to Assess the Quality of Life Outcomes of Indian Breast Cancer Patients

    Jun 1, 2012, 00:00

  • PRM18 Review of Administration's Cost Assumption of Rotavirus and Pneumococcal Vaccines Cost-Effectiveness Analyses

    Jun 1, 2012, 00:00

  • PMH52 Levomilnacipran in the Treatment of Major Depressive Disorder- Functional Health and Well-Being Efficacy Results from a Phase III Clinical Trial

    Jun 1, 2012, 00:00

  • PDB81 Value of a Diabetes Prevention Program in Rural Kenya- Comparing Payment Card and Structured Haggling Willingness to Pay Methods

    Jun 1, 2012, 00:00

  • PMS62 Predictors of Health Related Quality of Life in a Cohort of Patients with Rheumatoid Arthritis in Southern India

    Jun 1, 2012, 00:00

  • PSS1 Relieving the Pruritus of Atopic Dermatitis- A Meta-Analysis

    Jun 1, 2012, 00:00

  • PCV123 Can Modern Psychometric Approaches Improve Role Functioning Assessment in Acute Coronary Syndrome Patients? A Preliminary Trace-Core Analysis

    Jun 1, 2012, 00:00

  • PRS39 Palavizumab (Synagis) Use and Outcomes Among Medicaid Beneficiaries

    Jun 1, 2012, 00:00

  • PMH9 Description of the Burden Associated with Cognition Deficits in Schizophrenia

    Jun 1, 2012, 00:00

  • PIH18 Regional Cost-Effectiveness Analysis of Universal Childhood Hepatitis a Vaccination in Brazil

    Jun 1, 2012, 00:00

  • PCN26 A Budget Impact Analysis of Vinorelbine Introduction on Croatian Positive Drugs List in Breast Cancer Treatment

    Jun 1, 2012, 00:00

  • PSY17 Economic Burden Associated With Workplace Productivity Losses (WPL) in Patients With Psoriasis in a Population in the United States

    Jun 1, 2012, 00:00

  • PDB89 Real-World Management of Diabetes in Shanghai Minhang District

    Jun 1, 2012, 00:00

  • PIH67 Associations between Wellness Coaching and Changes in Health-Related Quality of Life

    Jun 1, 2012, 00:00

  • PCN158 Projecting State Level Estimates for Rare Disease Using Census Data and Healthe Care Claims Database

    Jun 1, 2012, 00:00

  • PRM4 Enhancing the Health Economic Value of Retrospective and Prospective Real-World Studies with Pharmacogenomic Testing- Opportunities and Challenges Associated with an Integrated Personalized Medicine Approach

    Jun 1, 2012, 00:00

  • PIH31 The Impact of Reducing Dosing Frequency of Oral Therapies on Adherence, Compliance, and Cost for Acute and Chronic Illnesses- A Meta-Analysis

    Jun 1, 2012, 00:00

  • PHP45 Burden of Illness of Chronic Conditions (CC) Among Hospitalized Patients- The Argentine-Health Care Cost and Utilization Project (A-HCUP)

    Jun 1, 2012, 00:00

  • PCN117 An Expert Panel Consensus on Medical Treatment of Non-Midgut Unresectable Neuroendocrine Tumors

    Jun 1, 2012, 00:00

  • PMD19 Multiple Daily Injection Therapy (MDI) Versus Durable Insulin Pump Therapy in Type II Diabetics- A Breakeven Analysis

    Jun 1, 2012, 00:00

  • PRS46 Evaluating the Prevalence Associated with Smoking Behavior among University Students in Pakistan

    Jun 1, 2012, 00:00

  • PIN50 How to Select Patient-Reported Outcome (PRO) Measures to Ensure Proper Evaluation of an Observational Study

    Jun 1, 2012, 00:00

  • PSU32 Asymptomatic Cholelithiasis in Kidney Transplant Recipients- Systematic Review of Surgery Appropriateness

    Jun 1, 2012, 00:00

  • PIH64 Burden of 100 Diseases within General Practi Results of the EPI3 Program

    Jun 1, 2012, 00:00

  • PCN64 The Cost Effectiveness of Cetuximab Plus Best Supportive Care (BSC) Versus BSC Alone in Last Line for KRAS Wild Type Metastatic Colorectal Cancer Patient Population

    Jun 1, 2012, 00:00

  • PMS13 Medication Adherence and Health Care Costs among Patients with Osteoarthritis Initiating Duloxetine Versus Celecoxib

    Jun 1, 2012, 00:00

  • PSY44 Examining Disease and Patient Characteristics of Individuals With Moderate-to-Severe Psoriasis in a Nationally Representative Population in the United States

    Jun 1, 2012, 00:00

  • PCN104 Performance Status of Patients With Advanced Melanoma Over Time in Routine Clinical Practice

    Jun 1, 2012, 00:00

  • CO4 Cost-Effectiveness Analysis - Appropriate for All Situations?

    Jun 1, 2012, 00:00

  • PSY68 Preferences for Immunoglobulin Treatment Administration Attributes by Patients and Parents

    Jun 1, 2012, 00:00

  • PSY19 Burden of Illness (BOI) of FLT3-Mutated Acute Myeloid Leukemia (AML)

    Jun 1, 2012, 00:00
  • «
  • 121
  • 122 (current)
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • »